eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | glycogen storage disease ii |
| Comorbidity | C0878544|cardiomyopathy |
| Sentences | 6 |
| PubMedID- 22572506 | We are presenting two cases of infantile form of pompe's disease with secondary hypertrophic cardiomyopathy (cmp). |
| PubMedID- 21211680 | Alglucosidase alpha (myozyme((r))) improves the cardiomyopathy and life expectancy of infants suffering from pompe disease and is under evaluation for the treatment of the juvenile and adult forms of the disease. |
| PubMedID- 25213570 | Hypertrophic cardiomyopathy in pompe disease is not limited to the classic infantile-onset phenotype. |
| PubMedID- 21940687 | Infantile-onset pompe disease presents with cardiomyopathy and hypotonia, leading to premature death. |
| PubMedID- 22736456 | A recent study demonstrated that a high-protein diet dramatically decreased the left ventricular mass index and serum creatine kinase levels and reversed cardiomyopathy in a patient with gsd iiia (dagli et al., 2009), indicating that this treatment is a beneficial therapeutic choice for gsd iiia patients with cardiomyopathy. |
| PubMedID- 21857385 | Successful treatment of severe cardiomyopathy in glycogen storage disease type iii with d,l-3-hydroxybutyrate, ketogenic and high-protein diet. |
Page: 1